We made a net profit after tax of 157m, though. The make up of our profit for 2024 will differ between royalties and milestones but we will make a profit for 2024, 2025, 2026 on Daybue alone if nothing changes. Our quarterly results show we’re producing free cash flow even with higher R&D costs (running the phase 2 trials). The severely contracted valuation already assumes Daybue growth will be modest in the largest (and only currently approved market), the US.
Share Price, page-10344
-
- There are more pages in this discussion • 2,471 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.27 |
Change
1.000(8.15%) |
Mkt cap ! $1.696B | |||
| Open | High | Low | Value | Volume |
| $12.95 | $13.39 | $12.79 | $9.854M | 751.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2545 | $13.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.29 | 1443 | 2 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |